Impax Laboratories Inc

Type: Company
Name: Impax Laboratories Inc
Nationality: United States
First reported 11 hours ago - Updated 1 hour ago - 2 reports

Impax Laboratories Stock Rating Lowered by Wunderlich (IPXL)

Several other analysts have also recently commented on the stock. Analysts at WallachBeth Capital downgraded shares of Impax Laboratories from a “buy” rating to a “hold” rating in a research note on Wednesday. Separately, analysts at JPMorgan Chase & ... [Published American Banking News - Stock Ratings - 1 hour ago]
First reported 3 hours ago - Updated 1 hour ago - 1 reports

IGI LABORATORIES : Announces Second Quarter 2014 Results

By a News Reporter-Staff News Editor at Biotech Business Week -- IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey based specialty generic drug development and manufacturing company, announced its financial results for the second quarter ended June ... [Published 4 Traders - 3 hours ago]
First reported 10 hours ago - Updated 7 hours ago - 2 reports

SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Violations of Federal Securities Laws by the Board of Directors of Impax Laboratories, Inc.

NEW YORK--(EON: Enhanced Online News)--Levi & Korsinsky, LLP is investigating Impax Laboratories, Inc. (“Impax” or the “Company”) (Nasdaq: IPXL) in connection with possible breaches of federal securities laws. ... [Published EON Business - 10 hours ago]
First reported 14 hours ago - Updated 11 hours ago - 2 reports

Impax preparing response to FDA Form 483 with 10 observations

Observations range from improper validation to out-of-specification test resultsImpax Laboratories said it is working to address issues raised in an FDA Form 483 for its Taiwanese manufacturing facility, which was cited with 10 observations following ... [Published In-Pharmatechnologist - 11 hours ago]
First reported Jul 29 2014 - Updated 11 hours ago - 3 reports

Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Impax Laboratories Inc.

First reported Jul 29 2014 - Updated 16 hours ago - 12 reports

Impax Labs Gets U.S. FDA Advisory Of Violations At Taiwan Factory

Related Biotechnology, Pharmaceutical and Healthcare NewsThe U.S. FDA dropped the flag on Impax Laboratories, citing 10 violations at its Taiwan production plant that makes the company's Rytary (carbidopa/levodopa) for Parkinson's disease set for agency ... [Published BioPortfolio - 16 hours ago]
First reported Jul 29 2014 - Updated 17 hours ago - 12 reports

Impax Laboratories Price Target Cut to $25.00 by Analysts at JPMorgan Chase & Co. (IPXL)

Stock analysts at JPMorgan Chase & Co. reduced their target price on shares of Impax Laboratories (NASDAQ:IPXL)A number of other analysts have also recently weighed in on IPXL. Analysts at Bank of America reiterated an "underperform" rating on shares ... [Published American Banking News - 17 hours ago]
First reported Jul 30 2014 - Updated 21 hours ago - 1 reports

INVESTOR ALERT: Investigation of Impax Laboratories, Inc. Announced by Glancy Binkow & Goldberg LLP

LOS ANGELES--(BUSINESS WIRE)--Contact Glancy Binkow & Goldberg LLP If you purchased Impax Laboratories, Inc. securities. ... [Published Business Wire Professional Services News - Jul 30 2014]
First reported Jul 29 2014 - Updated Jul 29 2014 - 2 reports

Indices Remain Mixed; Merck Beats Expectations

A few minutes into the final trading hour Tuesday, the Dow traded down 0.17 percent to 16,954.16 while the NASDAQ gained 0.16 percent ...Related Stocks:COMPANHIA DE SANEAMENTO B SICO DO ESTADO DE SAO PAULO-SABESP ADS'S COMPANHIA ENERGETICA CORNING INCORPORATED ... [Published Stock Nod - Jul 29 2014]
First reported Jul 29 2014 - Updated Jul 29 2014 - 1 reports

Markets modestly higher on home prices

The markets traded modestly higher during the midday with the Dow rising 14 points to 16,997 as home prices rose less than expected in May. Nasdaq gained 12 points to 4457.On the upsideSecond quarter earnings slipped for PGT ( Nasdaq: PGTI ) but the results ... [Published Securities Technology Monitor - Jul 29 2014]
First reported Jul 29 2014 - Updated Jul 29 2014 - 2 reports

Markets Open Higher; Merck Posts Upbeat Profit

Following the market opening Tuesday, the Dow traded up 0.37 percent to 17,045.40 while the NASDAQ surged 0.52 percent to 4,467.96. ...Related Stocks:COMPANHIA ENERGETICA CORNING INCORPORATED CPFL ENERGIA S.A. Cognex Corp Consolidated Communications Holdings, ... [Published Minyanville - Jul 29 2014]
First reported Jul 29 2014 - Updated Jul 29 2014 - 1 reports

U.S. FDA raises concerns about Impax's Taiwanese plant

July 29 (Reuters) - Impax Laboratories Inc said the U.S. Food and Drug Administration issued "certain observations" after an inspection of the company's manufacturing plant in Taiwan.The regulator issued a ten observations in a Form 483, which is usually ... [Published CNBC - Jul 29 2014]

Quotes

Fred Wilkinson, president and CEO of Impax Laboratories, said in a statement: " We are already working diligently to address the observations raised by the"
Original Article: NEXT ARTICLE More From BioPortfolio on "Impax Labs Gets U S FDA Advisory Of Violations At Taiwan Factory"
...15 business day period from the receipt of the Form 483," said Fred Wilkinson, president and chief executive officer of Impax Laboratories. "We remain committed to our overarching goal of implementing a world class continuous quality improvement program and maintaining the highest quality standards across our facilities."
The analysts wrote, "We are raising our DCF-based price objective from $27 to $28 based mainly on rolling forward our discount period to mid-2015 (vs. end-2014). We did not make any substantial changes to our model, which we updated for Rx trends in the Parkinson’s market that drives our Rytary estimates. We remain cautious on IPXL shares as our model already builds in significant value for new launches (including Rytary) and because IPXL’s FDA issues are as yet unresolved. That said, we believe IPXL, with new CEO Fred Wilkinson (ex-Actavis) at its helm, could engage in business development activity, which could present a risk to our thesis; recall that IPXL remains cash-rich (~$6/share)."

More Content

All (166) | News (118) | Reports (0) | Blogs (39) | Audio/Video (0) | Fact Sheets (0) | Press Releases (9)
sort by: Date | Relevance
Impax Laboratories Stock Rating Lowered by Wund... [Published American Banking News - Stock Ratings - 1 hour ago]
IGI LABORATORIES : Announces Second Quarter 201... [Published 4 Traders - 3 hours ago]
Stock Analysts’ Downgrades for July, 30th (ABG,... [Published Mideast Time - 6 hours ago]
Will Teva Pharmaceutical (TEVA) Beat Q2 Earning... [Published Yahoo! Finance - 7 hours ago]
Hottest Healthcare Stocks Now – AEGR REGN EXAM EW [Published InvestorPlace.com - 9 hours ago]
SHAREHOLDER ALERT: The Law Firm of Levi & Korsi... [Published EON Business - 10 hours ago]
SHAREHOLDER ALERT: The Law Firm of Levi & Korsi... [Published Business Wire Professional Services News - 10 hours ago]
WallachBeth Capital Downgrades Impax Laboratori... [Published American Banking News - Stock Ratings - 11 hours ago]
Impax preparing response to FDA Form 483 with 1... [Published In-Pharmatechnologist - 11 hours ago]
FDA performs inspection of Impax's Taiwan facility [Published Pharma Letter - 14 hours ago]
Impax Labs Gets U.S. FDA Advisory Of Violations... [Published BioPortfolio - 16 hours ago]
Impax Laboratories Price Target Cut to $25.00 b... [Published American Banking News - 17 hours ago]
Impax Labs Gets U.S. FDA Advisory Of Violations... [Published Health News Daily - 17 hours ago]
INVESTOR ALERT: Investigation of Impax Laborato... [Published Business Wire Professional Services News - Jul 30 2014]
FDA Issued Form 483 with 10 Inspectional Observ... [Published BioMedReports - Jul 30 2014]
SHAREHOLDER ALERT: Pomerantz Law Firm Investiga... [Published Bio-Medicine - Jul 29 2014]
Cowen and Company Downgrades Impax Laboratories... [Published American Banking News - Stock Ratings - Jul 29 2014]
Impax Laboratories Rating Reiterated by Bank of... [Published American Banking News - Jul 29 2014]
FDA cites inspection observations at Impax' man... [Published FirstWord Pharma - Jul 29 2014]
Impax smacked after FDA inspection [Published Seeking Alpha - Jul 29 2014]
Indices Remain Mixed; Merck Beats Expectations [Published Stock Nod - Jul 29 2014]
Indices Remain Mixed; Merck Beats Expectations [Published Minyanville - Jul 29 2014]
Markets modestly higher on home prices [Published Securities Technology Monitor - Jul 29 2014]
SHAREHOLDER ALERT: Pomerantz Law Firm Investiga... [Published Indianapolis Business Journal - Jul 29 2014]
SHAREHOLDER ALERT: Pomerantz Law Firm Investiga... [Published Pettinga Financial Advisors - Jul 29 2014]
SHAREHOLDER ALERT: Pomerantz Law Firm Investiga... [Published InvestorPoint.com - Jul 29 2014]
SHAREHOLDER ALERT: Pomerantz Law Firm Investiga... [Published Financial Services - Jul 29 2014]
Impax Laboratories Inc (IPXL) Slumps On Possibl... [Published Value Walk - Jul 29 2014]
Sellers Reduce Exposure to Shares of Impax Labo... [Published Individual.com - Jul 29 2014]
Impax Parkinson's drug future shaky as FDA flag... [Published DailyMe.Com - Jul 29 2014]
1 2 3 4 5 6
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
SHAREHOLDER ALERT: The Law Firm of Levi & Korsi... [Published EON Business - 10 hours ago]
NEW YORK--(EON: Enhanced Online News)--Levi & Korsinsky, LLP is investigating Impax Laboratories, Inc. (“Impax” or the “Company”) (Nasdaq: IPXL) in connection with possible breaches of federal securities laws. ...
SHAREHOLDER ALERT: The Law Firm of Levi & Korsi... [Published Business Wire Professional Services News - 10 hours ago]
NEW YORK--(BUSINESS WIRE)--Levi & Korsinsky, LLP is investigating Impax Laboratories, Inc. (“Impax” or the “Company”) (Nasdaq: IPXL) in connection with possible breaches of federal securities laws. ...
INVESTOR ALERT: Investigation of Impax Laborato... [Published Business Wire Professional Services News - Jul 30 2014]
LOS ANGELES--(BUSINESS WIRE)--Contact Glancy Binkow & Goldberg LLP If you purchased Impax Laboratories, Inc. securities. ...
FDA Performs Inspection of Impax's Taiwan Facility [Published PR Newswire: Health - Jul 29 2014]
HAYWARD, Calif., July 29, 2014 /PRNewswire/ -- Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that the U.S. Food and Drug Administration (FDA) performed a general GMP  inspection and a Pre-Approval Inspection (PAI) for RYTARYTM at the Company's ...
NIRI President and CEO Jeffrey D. Morgan to Ste... [Published PR.com Press Releases - Jul 18 2014]
Alexandria, VA, July 18, 2014 --( PR.com )-- The National Investor Relations Institute (NIRI) today announced that President and CEO Jeffrey D. Morgan will resign his position effective October 12, 2014, to pursue an opportunity with another association. ...
1 2 3 4 5 6 7 8

Press Releases

sort by: Date | Relevance
SHAREHOLDER ALERT: Pomerantz Law Firm Investiga... [Published Financial Services - Jul 29 2014]
Shareholder Alert: Bronstein, Gewirtz & Grossma... [Published Financial Services - Jul 29 2014]
Pharma Stocks under Review -- Impax Laboratorie... [Published Financial Services - Jul 23 2014]
Kosher Certifications, Biologic License Applica... [Published Financial Services - Jul 07 2014]
Patient Enrollments, Innovation Awards, Appoint... [Published Financial Services - Jun 25 2014]
1 2
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.